Growth inhibition by acycloguanosine of herpesviruses isolated from human infections.
about
Inhibition of cellular DNA polymerase alpha and human cytomegalovirus-induced DNA polymerase by the triphosphates of 9-(2-hydroxyethoxymethyl)guanine and 9-(1,3-dihydroxy-2-propoxymethyl)guanineUse of an enzyme-linked immunosorbent assay performed directly on fixed infected cell monolayers for evaluating drugs against varicella-zoster virusAntiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell cultureInhibition of human cytomegalovirus replication by 9-(1,3-dihydroxy-2-propoxymethyl)guanine alone and in combination with human interferonsEffect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in micePathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivoIn vitro susceptibility of varicella-zoster virus to acyclovirAcyclovir inhibition of Epstein-Barr virus replicationEfficacy of acyclovir against mouse cytomegalovirus in vivoInhibitory effects of antiherpesviral thymidine analogs against varicella-zoster virusIn vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compoundsMode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesvirusesPharmacokinetics of oral acyclovir (Zovirax) in the eye.Antiviral selection in the management of acute retinal necrosis.Intraocular acyclovir levels after subconjunctival and topical administrationA comparison of local and systemic acyclovir in the management of herpetic disciform keratitisEffect of acyclovir on the proliferation of human fibroblasts and peripheral blood mononuclear cells.Lack of toxicity of acyclovir to granulocyte progenitor cells in vitro.New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease.Physical mapping of drug resistance mutations defines an active center of the herpes simplex virus DNA polymerase enzyme.Thymidine kinase not required for antiviral activity of acyclovir against mouse cytomegalovirusOrofacial infection of athymic mice with defined mixtures of acyclovir-susceptible and acyclovir-resistant herpes simplex virus type 1Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir.Synergistic activity of combinations of recombinant human alpha interferon and acyclovir, administered concomitantly and in sequence, against a lethal herpes simplex virus type 1 infection in mice.Inhibition of human cytomegalovirus by combined acyclovir and vidarabineSingle-dose pharmacokinetics of acyclovir.Acyclovir treatment of experimental simian varicella infection of monkeysAcyclovir therapy of neonatal herpes simplex virus type 2 infections in rabbitsEffect of acyclovir and interferon on human hematopoietic progenitor cells.Alpha interferon and acyclovir treatment of herpes simplex virus in lymphoid cell cultures.Effect of several antiviral agents on human lymphocyte functions and marrow progenitor cell proliferation.Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro.Susceptibility of vaccine strains of varicella-zoster virus to antiviral compoundsAntiviral therapy: current concepts and practicesResistance of herpes simplex virus to 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine: physical mapping of drug synergism within the viral DNA polymerase locusTopical Acyclovir for Recurrent Herpes Labialis in Primary Care: Critical appraisalTwo distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1.Resistance of herpes simplex virus to acycloguanosine: role of viral thymidine kinase and DNA polymerase loci.Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.Genomic localization, sequence analysis, and transcription of the putative human cytomegalovirus DNA polymerase gene.
P2860
Q24646311-94D99FC8-02C3-4E14-9F23-73EB28BFA040Q27478097-B384C656-2D2A-44C7-BA9B-6C3760FF9D9BQ28361902-01385D53-C6F4-459F-A8B6-4CAB5895A0F0Q28365700-7998A2D2-C9D5-4F0C-BF1C-42E0579159EDQ28365880-A8C6967B-7F42-476D-A965-746B483F17B8Q28366019-25376614-98C1-46BF-B515-11656020DB0DQ28366044-DD738C8E-EEA0-45DF-8EC1-1A620349A12CQ28366051-9087D7D4-9842-4841-AE33-704D204D6D39Q28366112-736FB027-0D5B-4D54-9A8E-AEFCFBBE1248Q28366145-3DFE1CD0-830E-473E-A316-EC4B65422B39Q28366155-F2C611FD-574C-4154-8195-D45750AD2E06Q28367379-1ECC158E-9C54-4369-B7C9-029AFEA6056CQ33643138-5680CEE6-6F73-4283-95EE-785E1F08B211Q33644146-66AFE03C-D6DC-400F-86BD-06401B8DE743Q33645082-FACAF497-DF34-435F-8D4A-7B10FEA64524Q33648007-E69A8EE9-F7A8-4B78-B3CD-71D8E9D1B4C6Q33729804-AB8D7585-CBAB-4897-8644-4DD41F5CD99CQ33733456-5C52149E-2849-435F-8A18-67A949AB2414Q34647592-3CE65CF7-4D8D-415C-B0FE-95DAD98A6E45Q35240584-FFD79D48-2EC3-4DEC-AF82-47FB8A553C3AQ35241214-A2E93D1B-4EA4-426A-A8EF-2DF884E3962FQ35244752-FB14C379-752E-4A7E-818A-F6C2AA1C8171Q35345912-632D70C7-0B3F-41BE-8DAF-2873A648A96EQ35571110-89F3000A-05FD-45A6-82DD-195C5838D187Q35642726-DB2C089E-081F-4CEA-B666-FD5E8ED02792Q35669348-5DA3E820-A566-4E2C-8FC4-5CBF26959A77Q35671376-4C5270C7-A1A2-4566-813D-34100626A5C5Q35671741-3A0EF031-DDC8-467E-A842-E12B6BB24A4CQ35673321-C5B978D3-8F04-415F-8BAD-30DE4EC85FD6Q35675172-C8F5DFDA-9A9B-4399-953D-E6799CB16974Q35740490-579716CA-F39C-4CDE-9161-1F1F9223A2EDQ35755008-9A7EEAA4-D3CA-4463-B76F-42EE2D02319BQ35758745-AA4E9EEE-D34C-4881-B185-75EB628C1FC3Q36070394-CB651899-1F64-4FE6-81DA-E8966F011FD1Q36252289-186BAC63-9606-4256-BFC6-F9012817AEEFQ36282949-AB497F84-690F-4540-BDDA-322FD46E518CQ36365046-DC04B95A-B980-4B52-835A-D0C6B06074D7Q36365079-93A3270D-4045-4A17-92FD-360F82043BD5Q36401565-2C64A97C-F830-4D9E-8AFE-0296254D783CQ36425945-0A603388-8647-46A8-A7B6-CE2A37AD942D
P2860
Growth inhibition by acycloguanosine of herpesviruses isolated from human infections.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh
1979年學術文章
@zh-hant
name
Growth inhibition by acycloguanosine of herpesviruses isolated from human infections.
@ast
Growth inhibition by acycloguanosine of herpesviruses isolated from human infections.
@en
type
label
Growth inhibition by acycloguanosine of herpesviruses isolated from human infections.
@ast
Growth inhibition by acycloguanosine of herpesviruses isolated from human infections.
@en
prefLabel
Growth inhibition by acycloguanosine of herpesviruses isolated from human infections.
@ast
Growth inhibition by acycloguanosine of herpesviruses isolated from human infections.
@en
P2093
P2860
P356
P1476
Growth inhibition by acycloguanosine of herpesviruses isolated from human infections.
@en
P2093
Crumpacker CS
Schnipper LE
P2860
P304
P356
10.1128/AAC.15.5.642
P407
P577
1979-05-01T00:00:00Z